Algorae Pharmaceuticals Limited (ASX:1AI)
Australia · Delayed Price · Currency is AUD 0.0090
0.00 (0.00%)
Sep 18, 2026, 2:45 PM AEST
Algorae Pharmaceuticals Market Cap
Algorae Pharmaceuticals has a market cap or net worth of 18.25 million as of September 17, 2026. Its market cap has increased by 54.49% in one year.
Market Cap
18.25M
Enterprise Value
14.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since September 1, 2004, Algorae Pharmaceuticals's market cap has increased from 12.17M to 18.25M, an increase of 49.97%. That is a compound annual growth rate of 1.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 18.25M | -22.82% |
| Dec 31, 2025 | 23.64M | 133.52% |
| Dec 30, 2024 | 10.12M | -39.06% |
| Dec 29, 2023 | 16.61M | 7.70% |
| Dec 30, 2022 | 15.42M | 185.23% |
| Dec 30, 2021 | 5.41M | -32.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 25.33M |
| Proteomics International Laboratories | 23.15M |
| Patrys | 22.94M |
| Imugene | 22.53M |
| Noxopharm | 19.97M |
| EZZ Life Science Holdings | 19.53M |
| Argenica Therapeutics | 19.27M |
| Neurotech International | 15.87M |